Statement from Health Canada Regarding CEN Biotech

Warning message

The subscription service is currently unavailable. Please try again later.

February 20, 2015

It has come to Health Canada’s attention that Creative Edge Nutrition, Inc. (CEN Biotech, Inc.) issued a February 19, 2015 Shareholder Update Statement which mischaracterizes the meaning of the Department’s recent action in respect of the application for a license to produce under the Marihuana for Medical Purposes Regulations (MMPR).

On February 13, 2015, Health Canada sent a "Notice of Intent to Refuse" to CEN Biotech in response to the license application. The MMPR requires that Health Canada give notice to any applicant to whom it intends to refuse a licence. The applicant is provided 20 days to provide written representations.

It is in the public interest to clarify Health Canada’s actions on this matter.

Contact information and the official notice on the Health Canada site

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.